These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Allograft Inflammatory Factor-1 Governs Hematopoietic Stem Cell Differentiation Into cDC1 and Monocyte-Derived Dendritic Cells Through IRF8 and RelB Elizondo DM; Brandy NZD; da Silva RLL; Haddock NL; Kacsinta AD; de Moura TR; Lipscomb MW Front Immunol; 2019; 10():173. PubMed ID: 30800127 [TBL] [Abstract][Full Text] [Related]
9. Dendritic cells generated with Flt3L and exposed to apoptotic cells lack induction of T cell anergy and Foxp3⁺ regulatory T cell conversion in vitro. Pletinckx K; Lutz MB Immunobiology; 2014 Mar; 219(3):230-40. PubMed ID: 24252473 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of natural type I IFN-producing and dendritic cell development by a small molecule receptor tyrosine kinase inhibitor with Flt3 affinity. Tussiwand R; Onai N; Mazzucchelli L; Manz MG J Immunol; 2005 Sep; 175(6):3674-80. PubMed ID: 16148112 [TBL] [Abstract][Full Text] [Related]
11. Porcine Flt3 ligand and its receptor: generation of dendritic cells and identification of a new marker for porcine dendritic cells. Guzylack-Piriou L; Alves MP; McCullough KC; Summerfield A Dev Comp Immunol; 2010 Apr; 34(4):455-64. PubMed ID: 20015454 [TBL] [Abstract][Full Text] [Related]
12. Myeloid neoplasm-related gene abnormalities differentially affect dendritic cell differentiation from murine hematopoietic stem/progenitor cells. Fujita J; Mizuki M; Otsuka M; Ezoe S; Tanaka H; Satoh Y; Fukushima K; Tokunaga M; Matsumura I; Kanakura Y Immunol Lett; 2011 Apr; 136(1):61-73. PubMed ID: 21237204 [TBL] [Abstract][Full Text] [Related]
14. Flt3 ligand and granulocyte-macrophage colony-stimulating factor preferentially expand and stimulate different dendritic and T-cell subsets. Parajuli P; Mosley RL; Pisarev V; Chavez J; Ulrich A; Varney M; Singh RK; Talmadge JE Exp Hematol; 2001 Oct; 29(10):1185-93. PubMed ID: 11602320 [TBL] [Abstract][Full Text] [Related]
15. Introduction of Human Flt3-L and GM-CSF into Humanized Mice Enhances the Reconstitution and Maturation of Myeloid Dendritic Cells and the Development of Foxp3 Iwabuchi R; Ikeno S; Kobayashi-Ishihara M; Takeyama H; Ato M; Tsunetsugu-Yokota Y; Terahara K Front Immunol; 2018; 9():1042. PubMed ID: 29892279 [TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses. Weigel BJ; Nath N; Taylor PA; Panoskaltsis-Mortari A; Chen W; Krieg AM; Brasel K; Blazar BR Blood; 2002 Dec; 100(12):4169-76. PubMed ID: 12393694 [TBL] [Abstract][Full Text] [Related]
17. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy. Harada S; Kimura T; Fujiki H; Nakagawa H; Ueda Y; Itoh T; Yamagishi H; Sonoda Y Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional control of dendritic cell development. Murphy KM Adv Immunol; 2013; 120():239-67. PubMed ID: 24070387 [TBL] [Abstract][Full Text] [Related]
20. Fms-like tyrosine kinase 3 ligand is required for thymic dendritic cell generation from bone marrow-derived CD117⁺ hematopoietic progenitor cells. Xu Y; Jiang D; Hu Y; Li Y; Zhang X; Wang J; Wang Y Mol Med Rep; 2015 Nov; 12(5):6969-75. PubMed ID: 26397863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]